Published On: Nov 23, 2016
The nephrology and urology devices market is highly fragmented in nature due to several sub-segments within the market. The field comprises devices for dialysis, lithotripsy, stents, neurostimulation, prostate treatment, among others. Dialysis represents the most prominent segment with a share worth over 75.0% in the total market. The three leaders in this segment as of 2011 estimations were Fresenius, Gambro, and Baxter. However, the 2012 acquisition of Gambro by Baxter has put the company ahead, particularly in dialysis devices, as Gambro was the second leading dialysis devices manufacturer. By 2017, the newly restructured union is expected to account for a market share of around 40%, which will put Fresenius behind in second place.
Other notable players in the global market for nephrology and urology devices are Nipro and Nikkiso. The sacral neuromodulation segment is currently led by Medtronic, which is predicted to be the only company in the field.
The global market for nephrology and urology devices is estimated to reach a valuation of US$20.5 bn by 2018, rising at a healthy CAGR during the forecast period of 2012 to 2018.
Dialysis Equipment Remains in Demand
Dialysis equipment has emerged as the most prominent segment in the global market for nephrology and urology devices, followed by devices treating kidney and bladder stones. The dialysis equipment market comprises dialyzers required for filtration. The report observes that the trend is shifting from the use of reusable dialyzers to disposable ones. This has been advised and accepted in order to decrease the rate of infection arising from reusable dialyzers and the increasing incidence of blood-related diseases. The incontinence and prolapse devices segment is also likely to exhibit a healthy growth rate.
Geographically, Europe was estimated to be the most significant market in the nephrology and urology devices market, followed by North America. Europe led the key markets of dialysis and sacral neurostimulation. North America is expected to expand its sacral neurostimulation market in coming years and nibble into the share of Europe. Asia Pacific is expected to be remain in the third place, followed by Rest of the World.
Swelling Diabetic Population Driving Demand
According to current statistics by the National Health and Nutrition Examination Survey (NHANES) and National Kidney Foundation, more than 26 million Americans have chronic kidney diseases (CKD) and about 20 million are living with hypertension or diabetes. Incidences of CKD in other region such as Asia Pacific, Europe, and the Middle East are also rising quickly with increasing geriatric population, consequently driving the global market for nephrology and urology devices. Other factors that will favor the expansion of this market are: the growing popularity of minimally invasive and non-invasive treatment procedures, the rising market for advanced lithotripters in developed regions, innovation and new product development to improve the efficacy of urology disease treatment process, and favorable healthcare policies, especially in developed countries.
Conversely, factors that may hinder the growth rate of the global market for nephrology and urology devices include: high installation prices of lithotripters devices and advanced machines, the slow growth in healthcare spending in developed markets, and the lack of awareness about advanced technologies in emerging markets.
According to the author of the report, “Traditionally price-sensitive markets in the regions of Asia Pacific and the Middle East are providing new opportunities with many healthcare providers adopting advanced technologies that can satisfy the needs of a growing patient base and also fit into their budget. Government initiatives towards improving healthcare infrastructure in these regions is also aiding the expansion of the nephrology and urology devices market.”
The information presented in this review is based on a Transparency Market Research report, titled, “Nephrology and Urology Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 - 2018.”
Key Segments of the Global Nephrology and Urology Devices Market
Global Nephrology and Urology Devices Market, by Device
- Dialysis Devices
- Urinary Stone Treatment
- Urinary Incontinence and Pelvic Organ Prolapse Treatment
- Benign Prostatic Hyperplasia Devices
- Endoscopy Devices
Global Nephrology and Urology Devices Market, by Geography
- North America
- Asia Pacific
- Rest of the World (RoW)
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453